Khan Sidrah, Kotcher Rebecca, Herman Paul, Wang Li, Tessler Robert, Cunningham Kellie, Celebrezze James, Medich David, Holder-Murray Jennifer
Department of Surgery, University of Pittsburgh Medical Center, Kaufmann Medical Building, Suite 603, 3471 Fifth Avenue, Pittsburgh, PA, 15213, USA.
Department of Surgery, University of Washington Medical Center, Seattle, WA, USA.
Int J Colorectal Dis. 2024 Mar 11;39(1):37. doi: 10.1007/s00384-024-04602-1.
Surgery for anal fistulas can result in devastating complications, including reoperations and fecal incontinence. There is limited contemporary evidence comparing outcomes since the adoption of the ligation of intersphincteric fistula tract procedure into mainstream practice. The purpose of this study is to compare recurrence rates and long-term outcomes of anal fistula following repair.
Data was collected from the electronic medical records or patient reported outcomes from patients aged 18 or older with a primary or recurrent cryptoglandular anal fistula. Primary outcome was recurrence defined as the identification of at least one fistula os or a high clinical suspicion of anal fistula. Secondary outcomes included fecal incontinence and postoperative quality of life.
A total of 171 patients underwent definitive surgical repairs for their anal fistula. So 66.5% had a simple fistula, and 33.5% had a complex fistula. Of the 171 patients, 12.5% had a recurrence. The recurrence rates were 5.9% for simple fistula and 25.4% for complex fistula. Predictors of recurrence included diabetes mellitus, history of anorectal abscess, complex fistula, and sphincter sparing surgery. LIFT or plug/biologic procedures were both associated with a 50% or greater recurrence rate. No significant differences were found in fecal incontinence or associated quality of life between sphincter sparing or non-sphincter sparing surgical resections.
The study provides insights into the long-term outcomes of surgical repair for anal fistula. We demonstrate that sphincter sparing operations are associated with increased recurrence, meanwhile, non-sphincter sparing surgeries did not increase the risk of fecal incontinence or worsen quality of life.
肛瘘手术可能导致严重并发症,包括再次手术和大便失禁。自括约肌间瘘管结扎术被纳入主流实践以来,比较其疗效的当代证据有限。本研究的目的是比较肛瘘修复后的复发率和长期疗效。
收集18岁及以上原发性或复发性隐窝腺性肛瘘患者的电子病历或患者报告的结局数据。主要结局为复发,定义为至少发现一个肛瘘外口或高度怀疑存在肛瘘。次要结局包括大便失禁和术后生活质量。
共有171例患者接受了肛瘘确定性手术修复。其中,66.5%为单纯性肛瘘,33.5%为复杂性肛瘘。171例患者中,12.5%复发。单纯性肛瘘的复发率为5.9%,复杂性肛瘘为25.4%。复发的预测因素包括糖尿病、肛管直肠脓肿病史、复杂性肛瘘和保留括约肌手术。LIFT术或填塞/生物材料手术的复发率均在50%或更高。保留括约肌或不保留括约肌的手术切除在大便失禁或相关生活质量方面未发现显著差异。
本研究为肛瘘手术修复的长期疗效提供了见解。我们证明,保留括约肌的手术与复发率增加有关,同时,不保留括约肌的手术不会增加大便失禁的风险或使生活质量恶化。